Close Menu

NEW YORK – Genome engineering firm Synthego said on Wednesday that it has raised $100 million in a Series D financing round.

The round was led by new investor Wellington Management, as well as by RA Capital Management and 8VC. Founders Fund, Menlo Ventures, and Intel Capital also participated, the company said, noting that this new round brings its total private funding raised to more than $250 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.